The lawsuit against Wright stemmed from allegations that between 2002 and 2007 Wright had entered into consulting agreements with various orthopedic surgeons, which were designed and implemented, in part, to induce the surgeons to purchase and use its hip and knee reconstruction and replacement products.
In addition to the $7.9 million payment, Wright has also agreed to be under the review of a federal monitor, who will oversee Wright’s compliance with the terms of the prosecution agreement and all new and existing consulting agreements.
Read the DOJ news release about Wright Medical Technology’s settlement (pdf).
Read other coverage about pharmaceutical company settlements:
– Schwarz Pharma to Settle Allegations of False Claims, Will Pay $22M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.